Design and Synthesis of Non-peptidic Inhibitors for the Syk C-Terminal SH2 Domain Based on Structure-Based In-Silico Screening
- 14 November 2001
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 44 (26) , 4737-4740
- https://doi.org/10.1021/jm010313k
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Coumarin and Chromen-4-one Analogues as Tautomerase Inhibitors of Macrophage Migration Inhibitory Factor: Discovery and X-ray CrystallographyJournal of Medicinal Chemistry, 2000
- Structure-Based Design of Novel Bicyclic Nonpeptide Inhibitors for the Src SH2 DomainJournal of Medicinal Chemistry, 2000
- Tyrosine kinase SYK: essential functions for immunoreceptor signallingImmunology Today, 2000
- Structural basis for syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptideJournal of Molecular Biology, 1998
- Design of peptidomimetic ligands for the pp60src SH2 domainBioorganic & Medicinal Chemistry, 1997
- A human peptidyl–prolyl isomerase essential for regulation of mitosisNature, 1996
- Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptideStructure, 1995
- Backbone Dynamics of a Free and a Phosphopeptide-Complexed Src Homology 2 Domain Studied by 15N NMR RelaxationBiochemistry, 1994
- Preparation of fluoro- and hydroxy-4-(phosphonomethyl)-D,L-phenylalanine suitably protected for solid-phase synthesis of peptides containing hydrolytically stable analogs of O-phosphotyrosineThe Journal of Organic Chemistry, 1993
- Structure-Based Strategies for Drug Design and DiscoveryScience, 1992